The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANAPTYSBIO INC | COM | 032724106 | 7,276,289 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 7,942,400 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 7,381,005 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 10,527,461 | 310,270 | SH | SOLE | 310,270 | 0 | 0 | |||
CIDARA THERAPEUTICS INC | COM | 171757107 | 1,281,997 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,358,810 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 15,538,394 | 862,286 | SH | SOLE | 862,286 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 21,686,825 | 488,442 | SH | SOLE | 488,442 | 0 | 0 | |||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 118,346,875 | 5,798,475 | SH | SOLE | 5,798,475 | 0 | 0 | |||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 66,742,858 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | |||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 1,803,741 | 152,022 | SH | SOLE | 152,022 | 0 | 0 | |||
HOMOLOGY MEDICINES INC | COM | 438083107 | 4,014,288 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | |||
IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 3,663,685 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 4,293,450 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 6,955,025 | 192,500 | SH | SOLE | 192,500 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 18,231,786 | 357,486 | SH | SOLE | 357,486 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 8,896,264 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | |||
RALLYBIO CORP | COM | 75120L100 | 20,549,898 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | |||
SCPHARMACEUTICALS INC | COM | 810648105 | 12,234,593 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | |||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 5,082,600 | 2,364,000 | SH | SOLE | 2,364,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 9,482,850 | 585,000 | SH | SOLE | 585,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,661,200 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | |||
VOR BIOPHARMA INC | COM | 929033108 | 19,657,724 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | |||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 13,822,900 | 490,000 | SH | SOLE | 490,000 | 0 | 0 |